135 related articles for article (PubMed ID: 21131061)
1. Eicosapentaenoic acid decreases TNF-α and protects dystrophic muscles of mdx mice from degeneration.
Machado RV; Mauricio AF; Taniguti AP; Ferretti R; Neto HS; Marques MJ
J Neuroimmunol; 2011 Mar; 232(1-2):145-50. PubMed ID: 21131061
[TBL] [Abstract][Full Text] [Related]
2. Effects of fish oil containing eicosapentaenoic acid and docosahexaenoic acid on dystrophic mdx mice.
Fogagnolo Mauricio A; Minatel E; Santo Neto H; Marques MJ
Clin Nutr; 2013 Aug; 32(4):636-42. PubMed ID: 23218947
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine treatment reduces TNF-α levels and myonecrosis in diaphragm muscle of mdx mice.
de Senzi Moraes Pinto R; Ferretti R; Moraes LH; Neto HS; Marques MJ; Minatel E
Clin Nutr; 2013 Jun; 32(3):472-5. PubMed ID: 22727548
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice.
Messina S; Bitto A; Aguennouz M; Minutoli L; Monici MC; Altavilla D; Squadrito F; Vita G
Exp Neurol; 2006 Mar; 198(1):234-41. PubMed ID: 16410003
[TBL] [Abstract][Full Text] [Related]
5. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
6. Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment.
Radley HG; Davies MJ; Grounds MD
Neuromuscul Disord; 2008 Mar; 18(3):227-38. PubMed ID: 18207402
[TBL] [Abstract][Full Text] [Related]
7. Long-Term Therapy With Omega-3 Ameliorates Myonecrosis and Benefits Skeletal Muscle Regeneration in Mdx Mice.
Apolinário LM; De Carvalho SC; Santo Neto H; Marques MJ
Anat Rec (Hoboken); 2015 Sep; 298(9):1589-96. PubMed ID: 26011009
[TBL] [Abstract][Full Text] [Related]
8. Diltiazem and verapamil protect dystrophin-deficient muscle fibers of MDX mice from degeneration: a potential role in calcium buffering and sarcolemmal stability.
Matsumura CY; Pertille A; Albuquerque TC; Santo Neto H; Marques MJ
Muscle Nerve; 2009 Feb; 39(2):167-76. PubMed ID: 19145649
[TBL] [Abstract][Full Text] [Related]
9. EPA protects against muscle damage in the mdx mouse model of Duchenne muscular dystrophy by promoting a shift from the M1 to M2 macrophage phenotype.
Carvalho SC; Apolinário LM; Matheus SM; Santo Neto H; Marques MJ
J Neuroimmunol; 2013 Nov; 264(1-2):41-7. PubMed ID: 24090650
[TBL] [Abstract][Full Text] [Related]
10. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1.
De Luca A; Pierno S; Liantonio A; Cetrone M; Camerino C; Fraysse B; Mirabella M; Servidei S; Rüegg UT; Conte Camerino D
J Pharmacol Exp Ther; 2003 Jan; 304(1):453-63. PubMed ID: 12490622
[TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid protects the diaphragm muscle against myonecrosis in mdx mice.
Tonon E; Ferretti R; Shiratori JH; Santo Neto H; Marques MJ; Minatel E
Nutrition; 2012 Jun; 28(6):686-90. PubMed ID: 22189191
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of L-arginine benefits mdx skeletal muscle function.
Barton ER; Morris L; Kawana M; Bish LT; Toursel T
Muscle Nerve; 2005 Dec; 32(6):751-60. PubMed ID: 16116642
[TBL] [Abstract][Full Text] [Related]
13. Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.
Hnia K; Hugon G; Rivier F; Masmoudi A; Mercier J; Mornet D
Am J Pathol; 2007 Feb; 170(2):633-43. PubMed ID: 17255331
[TBL] [Abstract][Full Text] [Related]
14. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of Eugenia punicifolia extract on muscular lesion of mdx dystrophic mice.
Leite PE; de Almeida KB; Lagrota-Candido J; Trindade P; da Silva RF; Ribeiro MG; Lima-Araújo KG; Santos WC; Quirico-Santos T
J Cell Biochem; 2010 Dec; 111(6):1652-60. PubMed ID: 21053281
[TBL] [Abstract][Full Text] [Related]
16. L-arginine improves dystrophic phenotype in mdx mice.
Voisin V; Sébrié C; Matecki S; Yu H; Gillet B; Ramonatxo M; Israël M; De la Porte S
Neurobiol Dis; 2005 Oct; 20(1):123-30. PubMed ID: 16137573
[TBL] [Abstract][Full Text] [Related]
17. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice.
Hodgetts S; Radley H; Davies M; Grounds MD
Neuromuscul Disord; 2006 Oct; 16(9-10):591-602. PubMed ID: 16935507
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
Grounds MD; Torrisi J
FASEB J; 2004 Apr; 18(6):676-82. PubMed ID: 15054089
[TBL] [Abstract][Full Text] [Related]
19. Normal myoblast implantation in MDX mice prevents muscle damage by exercise.
Brussee V; Merly F; Tardif F; Tremblay JP
Biochem Biophys Res Commun; 1998 Sep; 250(2):321-7. PubMed ID: 9753628
[TBL] [Abstract][Full Text] [Related]
20. The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.
Messina S; Bitto A; Aguennouz M; Vita GL; Polito F; Irrera N; Altavilla D; Marini H; Migliorato A; Squadrito F; Vita G
Neuromuscul Disord; 2011 Aug; 21(8):579-89. PubMed ID: 21658942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
